Hamburg: FDA needs more authority for fakes-fighting; manufacturing mishap delays Onyx NDA filing;

> "The FDA needs new regulatory tools that provide the authority we need to meet the challenges in today's increasing globalized marketplace," Commissioner Margaret Hamburg told the Counterfeit Drug Interchange Conference. Article

> Following the discovery of product variations thought to be caused by faulty equipment during an early manufacturing-scale run, Onyx Pharmaceuticals has delayed its NDA filing for multiple myeloma drug candidate carfilzomib. Article

> The pharmaceutical sector is one of three manufacturing clusters in which U.K. and Singaporean capabilities "combine to create the ideal platform for companies seeking to serve Asian markets," says Singapore's Minister for Trade & Industry.  Article

> Big 3 distributor McKesson held a groundbreaking ceremony for a 340,000-square-foot distribution center in Carmel Church, Caroline County, VA. Article

> India's drug control officers are calling on the Union Health Ministry to form a national drug information center. Article

> ProximaRF Technology has announced a distribution agreement with Meridius for use of the former's passive temperature sensors and data loggers in cold chain applications. Article

> Metrics' senior formulations scientist Joe Cobb has earned the ISPE Certified Pharmaceutical Industry Professional credential. Metrics release

> Thermo Fisher Scientific says it has developed a method for the identification, confirmation and quantitation of illicit drugs and their salt forms. News

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.